Prosight Management’s Chemed CHE Stock Holding History

Prosight Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,500	Closed	-$1.3M	–	36
2023 Q3	$1.3M	Buy	+2,500	New	+$1.3M	0.41%	37

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Prosight Management's CHE Position: Q4 2023 in Review

Prosight Management sold out of Chemed (CHE) in Q4 2023, closing a stake of 2,500 shares — an estimated $1.3M sold.

Prosight Management first reported a position in CHE in Q3 2023 and held it in 1 quarter. The position peaked at $1.3M in Q3 2023. 501 funds tracked by Wall St. Rank hold CHE as of Q4 2023.

Prosight Management reported no remaining Chemed position as of Q4 2023 after selling out during the quarter.
Prosight Management sold 2,500 Chemed shares in Q4 2023, an estimated $1.3M.
Prosight Management first reported a position in Chemed in Q3 2023 and held it in 1 quarter.
Prosight Management's Chemed position peaked at $1.3M in Q3 2023.
501 funds tracked by Wall St. Rank held Chemed as of Q4 2023.

Based on Prosight Management's 13F filing for Q4 2023, filed 14 Feb 2024.